Ftse Mib
37.675,40
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.571,83
-0,76%
NASDAQ
17.367,93
-0,57%
Bitcoin
81.747,45
4,19%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Deciphera Pharmaceuticals Inc (DCPH) Deciphera Pharmaceuticals Inc (DCPH) Notizie

Deciphera Pharmaceuticals Inc

DCPH
25,59
0,00 (0,00%)
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/6/202414:02EDGAR2Form 15-12G - Securities registration termination [Section..
14/6/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
12/6/202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202423:18EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/6/202423:02EDGAR2Form POS AM - Post-Effective amendments for registration..
11/6/202423:01EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
11/6/202415:25EDGAR2Form 8-K - Current report
11/6/202415:18EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/6/202415:15EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
03/6/202413:00EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
03/6/202413:00BWDeciphera Pharmaceuticals Announces Oral Presentation of..
28/5/202412:08EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
22/5/202415:06EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
22/5/202413:01EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
13/5/202412:32EDGAR2Form SC 14D9 - Solicitation, recommendation statements
13/5/202412:31EDGAR2Form SC TO-T - Tender offer statement by Third Party
10/5/202413:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202423:16EDGAR2Form SC TO-C - Written communication relating to an issuer..
29/4/202413:00BWDeciphera Pharmaceuticals to be Acquired by ONO..
09/4/202413:00BWDeciphera Pharmaceuticals to Present at the Stifel 2024..
Apertura: Min: Max:
Chiusura: 25,59

La tua Cronologia

NASDAQ
DCPH
Deciphera Pharmaceuticals
USOTC
FAXXF
Fairfax Financial (PK)
UNSW
XIOTUSDT
Xiotri
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci